Statistics and Interpretation of Evidence

Question 10 | Platform trials - definition, advantages, disadvantages |

Question 3 | Randomisation- simple, block, stratified and covariate adaptive |

Question 27 | Platform trials: design, advantages and disadvantages |

Question 7 | Terminology in statistics, including the ROC curve |

Question 10 |

Question 27 | Statistics definitions: external validity, concealment, stratification, etc |

Question 26.3 | Terminology in statistics: odds ratio, CI and P value |

Question 26.2 | Terminology in statistics: odds ratio, CI and P value |

Question 26.1 | Terminology in statistics: odds ratio, CI and P value |

Question 24 | Clinical trial methodology: a list of memorised definitions |

Question 22 |

Question 6 | Elements of randomisation |

Question 24 |

Question 28 |

Question 11 | Definitions of terms in statistics: prevalence, relative risk and attributable risk |

Question 20 |

Question 19 | Allocation concealment , block randomisation, stratification, minimisation algorithm. |

Question 8 | Anatomy of the forest plot; advantages and disadvantages of meta-analysis |

Question 13 | Meta-analysis: advantages and disadvantages. Also, the funnel plot |

Question 26 |

Question 5 | Meta-analysis: advantages and disadvantages. Also, publication bias. |

Question 8 | Analysis of clinical trials: overall assessment of quality |

Question 17 | Define "EBM"; also, levels of evidence and intention to treat analysis |

Question 23 | Definitions: Risk ratio, NNT, P-value and confidence interval. |

Question 29 |

Question 9 | Definitions Relative risk, absolute risk, NNT, and the power of a study. |

Question 19.2 | Calculate: Relative risk, absolute risk, NNT |

Question 19.1 | Calculate sensitivity, specificity, PPV and NPV |

Question 24 |

Question 10 | Meta-analysis: the forest plot. Its anatomy in some detail. |

Question 23 | Definitions: Type 1 error, type 2 error, study power, sample size and effect size. |

Question 29.2 | Calculate sensitivity, specificity, PPV and NPV. |

Question 29.1 | Definitions: Phase III trial, absolute and relative risk reduction, NNT. |

Question 30 | Meta-analysis: features suggestive of "high quality". |

Question 15 | Definitions: sensitivity, specificity, PPV NPV and the positive likelihood ratio. |

Question 10 | Define intention to treat analysis and randomisation. |

Question 25 | Definitions: relative risk, absolute risk, NNT and study power. |

Question 21 |

Question 13 | Definitions: sensitivity, specificity, PPV and NPV. |

Question 4 |

Question 6 | Analysis of clinical trials: Methodological quality |

Question 4 | Tests of statistical significance: Chi-squared test, Fisher’s Exact Test and logistic regression. |

Question 14 | Definitions: sensitivity, specificity, PPV and NPV. |

Question 2c | Analysis of clinical trials: criteria used to assess validity. |

Question 2b |